Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07357701 · ClinicalTrials.gov registry record
Identifying Genome Variants in Non-Obstructive Azoospermia (NOA) or Primary Ovarian Insufficiency (POI)
A clinical trial of Primary Ovarian Insufficiency and Azoospermia, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- Recruiting
- Registry status
- 500
- Enrollment target
- 2
- Study locations
NCT07357701: Recruiting study of Primary Ovarian Insufficiency and Azoospermia, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
NCT07357701 is a study of Primary Ovarian Insufficiency and Azoospermia that is actively recruiting participants, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 500 participants, above the 19-participant average among 3 other Primary Ovarian Insufficiency trials with a reported enrollment target (2532% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07357701, a study of Primary Ovarian Insufficiency and Azoospermia, is actively recruiting participants, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 2
- Study locations
Study Summary
Background: Infertility affects 1 in 6 people. Often, the causes of infertility are unknown. Treatments are successful in only about 50% of cases. Infertility caused by non obstructive azoospermia in males and primary ovarian insufficiency in females can have genetic causes. Researchers want to learn more about these genes. Objective: To identify genes that may cause infertility. Eligibility: Adult men and women with non-obstructive azoospermia (NOA) or primary ovarian insufficiency (POI) of unknown cause. Design: Participants will provide a saliva sample. A kit will be sent to their home. The kit will contain a collection tube and a cotton swab. They will swirl the swab inside their mouth and then seal it in the tube. They will mail the tube back to the researchers. Male participants who are having a procedure done to collect tissue from their testes may opt to have leftover tissue provided to study researchers. This tissue would otherwise have been discarded. No new procedures will be performed just for this study. Data may be collected from participants medical records.
Primary Outcome
Across 5 years we will sequence patients with POI and NOA to determine genetic associations with infertility
Conditions Studied
Study Locations (2)
Maryland
- National Institutes of Health Clinical Center (Remote and In-Person) - Bethesda
- Shady Grove Fertility - Rockville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2026-03-11 |
| Est. Completion | 2031-01-01 |
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)305 total trials
What NCT07357701 shows while recruiting
NCT07357701 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 19-participant average among 3 other Primary Ovarian Insufficiency trials with a reported enrollment target (2532% higher).
The record links to 3 conditions, with Primary Ovarian Insufficiency appearing as the primary indexed condition, and to 0 interventions.
NCT07357701 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT07357701 about?
NCT07357701 is a clinical study titled "Identifying Genome Variants in Non-Obstructive Azoospermia (NOA) or Primary Ovarian Insufficiency (POI)". Background: Infertility affects 1 in 6 people. Often, the causes of infertility are unknown. Treatments are successful in only about 50% of cases. Infertility caused by non obstructive azoospermia in males and primary ovarian insufficiency in females can have genetic causes. Researchers want to lea...
What is the current status of trial NCT07357701?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2026-03-11. Estimated completion is 2031-01-01.
What conditions does trial NCT07357701 study?
This clinical trial studies the following conditions: Primary Ovarian Insufficiency, Azoospermia, Oligospermia.
Who is sponsoring clinical trial NCT07357701?
This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07357701 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Ovarian Insufficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Endometrial Thickness Among Adolescent and Young Adult Patients on Estrogen Replacement Therapy Using Daily Oral Micronized Progesterone Versus the Etonogestrel Implant.
RECRUITING
-
Primary Ovarian Insufficiency: Phenotype and Optimal Treatment
COMPLETED · Phase 3
-
Rejuvenation of Premature Ovarian Failure With Stem Cells
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI